[Role of carboplatin in the treatment of lung cancer]
- PMID: 11082721
[Role of carboplatin in the treatment of lung cancer]
Abstract
Carboplatin is a cytotoxic drug used in non-small cell and small cell lung cancer. Its role in advanced disease, but also in combination with radiotherapy, in neoadjuvant treatment and in the treatment approach in elderly patients is reviewed. New cytotoxic drug combinations are described.
Similar articles
-
Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.Lung Cancer. 2007 Nov;58(2):238-45. doi: 10.1016/j.lungcan.2007.06.003. Epub 2007 Jul 20. Lung Cancer. 2007. PMID: 17658655 Clinical Trial.
-
[Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].Gan To Kagaku Ryoho. 2009 Oct;36(10):1653-6. Gan To Kagaku Ryoho. 2009. PMID: 19838022 Japanese.
-
A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.Anticancer Drugs. 2007 Jul;18(6):713-9. doi: 10.1097/CAD.0b013e328082558a. Anticancer Drugs. 2007. PMID: 17762402 Clinical Trial.
-
Recent advances in chemotherapy for lung cancer.Curr Opin Pulm Med. 1996 Jul;2(4):285-9. Curr Opin Pulm Med. 1996. PMID: 9363153 Review.
-
Combination chemotherapy and radiation therapy in lung cancer.Semin Oncol. 1994 Jun;21(3 Suppl 6):72-8. Semin Oncol. 1994. PMID: 8052877 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical